Proyecto de Investigación
Project DGU.PROY.17
ProID2017010094. Desarrollo de nuevos medicamentos para el tratamiento de la tuberculosis pediátrica: formas farmacéuticas de administración oral.
date_range
Duration: from 15 September 2017 to 30 April 2021
(43 months)
Finished
It has been granted under a regime of Competitive.
Call:
PI.ACIISI.17.02.06
Researchers
Publications related to the project
Show by yearArticle
-
Impact of storage conditions on a new child-friendly dispersible tablet for treating Tuberculosis in pediatrics.
2021
Pharmaceutical Sciences
-
Design and optimization of a child-friendly dispersible tablet containing isoniazid, pyrazinamide, and rifampicin for treating tuberculosis in pediatrics
2020
Drug Development and Industrial Pharmacy
-
Stability study of isoniazid and rifampicin oral solutions using hydroxypropyl-Β-cyclodextrin to treat tuberculosis in paediatrics
2020
Pharmaceutics
-
A High-Demanding Strategy to Ensure the Highest Quality Standards of Oral Liquid Individualized Medicines for Pediatric Use
2019
AAPS PharmSciTech
Thesis
-
Desarrollo y caracterización de formulaciones farmacéuticas adaptadas para pediatría
2020
Suárez González, Javier